4//SEC Filing
Agger Mette Kirstine 4
Accession 0000899243-20-016168
CIK 0001604950other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:18 PM ET
Size
5.3 KB
Accession
0000899243-20-016168
Insider Transaction Report
Form 4
Agger Mette Kirstine
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-09+6,124→ 6,124 totalExercise: $7.96Exp: 2030-06-09→ Common Stock (6,124 underlying)
Footnotes (1)
- [F1]This stock option vests in full upon the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
scPharmaceuticals Inc.
CIK 0001604950
Entity typeother
Related Parties
1- filerCIK 0001722234
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 4:18 PM ET
- Size
- 5.3 KB